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Abstract: Marsilea crenata Presl. is a plant that widely used as traditional food in Surabaya, Indonesia. Although in 
some research it was known contain phytoestrogens which have activity in bone formation, the 
phytochemical properties of M. crenata has not been completely confirmed yet. The aim of this research 
was to determine the metabolite profile of ethyl acetate extract of M. crenata using UPLC-QToF-MS/MS, 
which can be used as a reference for further research and utilization of M. crenata. Dried powder of M. 
crenata was extracted with n-hexane followed by ethyl acetate. The 100 ppm of ethyl acetate extract in 
DCM and methanol then injected 5 µl each into the UPLC-QToF-MS/MS. The results were analyzed by 
Masslynx 4.1 software, and showed various types of compounds, either detected compounds (36 
compounds), or unknown compounds. 
1 INTRODUCTION 
Marsilea. crenata Presl. is an aquatic plant that 
widely used as an ingredient for traditional food in 
Surabaya, Indonesia (Nurjanah and Abdullah, 2012; 
Ma’arif et al., 2016).  
 
 
 
 
 
 
 
 
 
 
Figure 1: Marsilea crenata Presl. 
 
Some of the research that had been done showed 
that 96% ethanol extract, n-hexane extract, and ethyl 
acetate extract of M. crenata leaves can inhibit 
osteoporosis in female mouse (mus musculus) with 
mechanism of bone formation improvement 
(Laswati, 2011; Aemi, 2012; Adityara, 2017; 
Widiasari, 2017). Other studies were also showed 
that n-hexane extract of M. crenata leaves can 
increase the alkaline phosphatase production in 
MC3T3-E1 preosteoblast cell differentiation 
process, which indirectly also play a role in bone 
formation improvement (Ma’arif et al., 2018).  
This activity appears to be suspected because of 
the phytoestrogens content in M. crenata, where 
phytoestrogens can bind to estrogen receptors (ERs) 
in osteoblasts to increase their activity (Cos et al., 
2003; Villiers, 2009). Phytoestrogens are a group of 
compounds contained in plants which have estrogen-
like structures or can replace the function of 
estrogen, both in association with estrogen receptors 
(ER-dependent) and not (ER-independent) (Ososki 
and Kennelly, 2003; Yang et al., 2012; Cui et al., 
2013). 
Although it has great potential as a medicinal 
plants, the phytochemical properties of M. crenata 
has not been completely confirmed yet. This 
research was done to identify the metabolite profile 
of ethyl acetate extract of M. crenata using UPLC-
QToF-MS/MS, which can be used as a reference for 
further research and utilization of M. crenata. 
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 UPLC-QToF-MS/MS is a powerful technique used 
for metabolite profiling which has improved in 
performance of chromatographic resolution, speed 
and sensitivity analysis, saves time, also reduces 
solvent consumption (Patil et al., 2011), 
The ethyl acetate extract was selected because in 
the preliminary study using TLC visualizer, this 
extract showed the best TLC profile (Figure 2). 
Whereas metabolite profiling of n-hexane extract has 
been done before (Ma’arif et al., 2016).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: TLC profile of : a. 96% ethanol extract; b. n-
hexane extract; c. ethyl acetate extract; and d. metanol 
extract; from M. crenata leaves at λ 366 nm. 
2 MATERIAL AND METHODS 
2.1 Material 
2.1.1 Plant Material 
M. crenata were collected in Benowo, Surabaya, 
Indonesia at November 2017, and identified in UPT 
Materia Medica, Batu, Indonesia at December 2017 
with specimen number 1a-17b-18a-1. The leaves 
were prepared to get dry powder of M. crenata. 
2.1.2 Chemical 
All chemicals were grade of analytical reagent and 
used as received. N-hexane, and ethyl acetate as 
solvent were purchased from Pharmacy Department, 
Faculty of Medical and Health Science, Maulana 
Malik Ibrahim State Islamic University. 
Dichloromethane, metanol, acetonitrile, and formic 
acid as solvent and mobile phase on UPLC-QToF-
MS/MS were purchased from Central Forensic 
Laboratory Badan Reserse Kriminal Kepolisian 
Negara Republik Indonesia. 
2.2 Methods 
2.2.1 Extraction 
Dry powder of M. crenata leaves were extracted 
with n-hexane first. Its residue then re-extracted with 
ethyl acetate. In the preliminary study, the 96% 
ethanol extract was obtained by directly extracting 
dry powder of M. crenata, while methanol extract 
was obtained from re-extracting residue of ethyl 
acetate extract with methanol. All extraction process 
was using ultrasonic assisted extraction method 
(Sonica 5300EP S3). This process was repeated, 
collecting all the supernatants, which were finally 
evaporated in a rotary evaporator (Heidolph) to get 
ethyl acetate extract. 
2.2.2 Analysis with UPLC-QToF-MS/MS 
A simple, rapid, reliable and precise reversed phase 
UPLC-QToF-MS/MS method has been developed 
and validated according to the regulator guidelines. 
The ethyl acetate preparation was done using solid 
phase extraction, 100 ppm of ethyl acetate extract in 
DCM and methanol then injected 5 µl each into the 
an ACQUITY UPLC® H-Class System (Waters, 
USA) coupled to an MS detector Xevo G2-S QToF 
(Waters, USA). Sample were separated on an 
ACQUITY BEH C18 (1.7 µm 2.1x50 mm) with 
acetonitril + 0.05 % formic acid and water + 0.05 % 
formic acid as mobile phase, with flowrate  0.2 
ml/min. The results of UPLC-MS analysis was 
processed using the Masslynx Version 4.1 software, 
to obtain the data of peak and m / z spectra of each 
detected peak. The compound content can then be 
predicted using the chemspider website. 
3 RESULTS AND DISCUSSION 
A total of 300 g dry powder of M. crenata leaves 
were extracted with n-hexane and then ethyl acetate 
to produce 2.82 g extract. The dry powder need to be 
extracted first with n-hexane to remove impurities 
which may interfere with the identification process, 
such as fatty acid compounds. Ethyl acetate extract 
of M. crenata were analysed by UPLC-QToF-
MS/MS to better interpret the diversity of available 
phytochemicals.  
 
 
a b c d 
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 Table 1: Predicted compounds of ethyl acetate extract from M. crenata leaves in DCM solvent 
No. RT (min) % Area Measured m/z Molecular Formula Proposed Metabolite Activity 
1 1.272 0.3022 150.0280 Unknown Unknown - 
2 1.420 0.2059 119.0944 Unknown Unknown - 
3 2.118 1.0502 201.1728 C11H23NO2 11-Aminoundecanoic acid - 
4 2.598 1.7620 122.0842 C7H10N2 2-Pyridylethylamine 
Histamine 
agonist 
(Kunkel and 
Dixon, 1984)
5 4.427 0.2680 301.1890 C15H27NO5 Megalanthonine 
Antifungal 
(Reina et al., 
1998)
6 4.828 0.0245 378.1862 C21H30O4S Tixocortol 
Corticosteroid, 
antiinflammato
ry (Friedman 
and Metcalfe, 
1991), 
decongestant 
(Cuenant et al., 
1986)
7 4.930 0.0063 299.1944 C12H29NO7 Unknown - 
8 5.193 0.0799 315.1134 Unknown Unknown - 
9 5.342 0.1373 149.1203 Unknown Unknown - 
10 5.479 0.0713 431.2729 Unknown Unknown - 
11 5.662 0.0830 210.1255 Unknown Unknown - 
12 5.959 0.0335 519.3245  C27H45N5O3S 
3,5-
Isothiazoledicarboxa
mide, 4-amino-
N3,N5-dicyclohexyl-
N5-[1-[[(3-
methylbutyl) amino] 
carbonyl]butyl]- 
- 
13 6.211 0.0193 545.3508 Unknown Unknown - 
14 6.623 0.0089 462.2615 C13H39N10O4PS Unknown - 
15 7.206 0.4010 196.1099 C11H16O3 1-carboxy-3-hydroxyadamantane - 
16 7.972 0.1522 271.1930 C12H26N5P 
Pyrrolidine, 1,1',1''-
(hydrazinylidenephos
phoranylidyne)tris- 
- 
17 9.733 0.0992 256,1936 C17H24N2 
1H-Benzimidazole, 
1-(2-
cyclohexylethyl)-5,6-
dimethyl- 
Antituberculos
is, antibacterial 
(Gobis et al., 
2015)
18 10.967 0.4997 191.1309 Unknown Unknown - 
19 11.448 1.0321 241.2772 C16H35N Hexadecylamine 
Antibacterial, 
adjuvant for 
diphtheria, 
tetanus toxoid, 
and 
antiinfluenza 
(Attwood and 
Florence, 
2012)
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 20 11.630 0.5779 386.1728 C22H26O6 
Benzophenone, 2-(1-
ethylacetonyl)-
3',4,4',5-
tetramethoxy- 
- 
21 11.882 0.0066 310.1203 C19H18O4 Benzylbutylphthalate 
Estrogenic 
activity (Harris 
et al., 1997)
22 12.111 0.1000 310.1775 C17H26O5 Portentol 
Antioxidant, 
anticancer 
(Schröckenede
r, 2012)
23 12.842 0.1933 3032925 C21H37N Pregnan-3-amine - 
24 13.345 0.0078 228.1152 C15H16O2 Bisphenol A 
Estrogenic 
activity 
(Hewitt and 
Korach, 2010)
25 13.940 0.1502 567.4201 C36H58NO2P 
Dibenzo[d,f][1,3,2]di
oxaphosphepin-6-
amine, N,N-dibutyl-
2,4,8,10-tetrakis(1,1-
dimethylethyl)- 
- 
26 14.077 0.1513 531.3416 C28H45N5O5 
Glycine, N-[[(E)-2-
(4-
methoxyphenyl)diaze
nyl]carbonyl]leucyl-, 
compd. with N-
cyclohexylcyclohexa
namine (1:1) 
- 
27 15.038 3.7928 627.1884 C33H30N5O6Cl 
1H,5H-Pyrrolo[3,4-
g][1,2,4]triazolo[1,2-
a]cinnoline-
1,3,8,10(2H,7H,9H)-
tetrone, 7-(3-chloro-
4-hydroxy-5-
methoxyphenyl)-
7a,10a,11,11a-
tetrahydro-2-methyl-
9-[(4-
methylphenyl)amino]
-7a-phenyl- 
- 
28 16.970 36.4625 775.2261 C38H38N5O11Cl 
(1R,13S,16S,17R,28
R)-28-Amino-20-
chloro-17,25-
dihydroxy-5,8,10,24-
tetramethoxy-N-
methyl-15,29,31-
trioxo-22-oxa-
14,30,32triazahexacy
clo 
[14.14.2.218,21.12,6.123,
27.07,12]hexatriaconta-
2(36),3,5 
,7,9,11,18,20,23(33),
24,26,34-dodecaene-
13-carboxamide 
- 
29 17.633 34.5167 592.2692 C30H33N12P Unknown - 
30 17.885 10.8884 849.2460 C52H41N5OPSCl Unknown - 
31 18.330 6.4550 701.2070 Unknown Unknown - 
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 32 21.658 0.0608 156.9950 C4H3N3O2S 
1H-Pyrazolo[3,4-
d]thiazole-
3,5(2H,6H)-dione 
- 
 
Table 2: Predicted compounds of ethyl acetate extract from M. crenata leaves in methanol solvent 
No. RT (min) % Area Measured m/z Molecular Formula Proposed Metabolite Activity 
1 0.581 0.0068 124.9797 C3H5NCl2 3,3-Dichloro-2-propen-1-amine - 
2 1.500 1.0634 235.1421 C10H22NO5 Nitromethanetrispropanol - 
3 2.266 0.1459 122.0478 C6H6N2O Nicotinamide 
Activity of 
diphosphate 
(ADP) -
ribosyltransfera
se (Maurer et 
al., 2012), anti-
SIRT2 (Cui et 
al., 2014).
4 4.016 0.0642 124.9789 Unknown Unknown  
5 5.045 0.1590 149.1201 C10H15N (S)-(+)-Methamphetamine 
Increase activit
y of 
neurotransmite
r norepinefrin 
and dopamine, 
reduce appetite 
(Ward et al., 
2016).
6 5.228 0.1070 431.2733 C18H41NO10 Unknown  
7 5.445 0.0977 466.2989 C33H37N3 
(1E)-1-(2,2'',4,4'',6,6''-
Hexamethyl1,1':3',1''-
terphenyl-2'-yl)-3-
mesityl-1-triazene 
- 
8 5.662 0.0169 519.3256 H34N31OCl Unknown  
9 7.206 4.6301 196.1102 C11H16O3 1-carboxy-3-hydroxyadamantane - 
10 8.006 0.2579 125.1882 C12H25NO2 12-Aminododecanoic acid 
Hamper 
expression of 
CD40 
(Albertshofer 
et al.,2005)
11 8.886 0.0908 119.0941 Unknown Unknown  
12 10.533 1.4306 180.1148 C11H16O2 2-tert-butyl-4-methoxyphenol 
Antioxidant 
(Lee et al., 
2006)
13 11.013 0.6199 224.1886 C13H24N2O 
Ethyl (4S)-5-
cyclohexyl-2,2-
difluoro-4-{[(2S)-2-
{[N-(4-
morpholinylsulfonyl)-
L-
phenylalanyl]amino}-
4-pentenoyl]amino}-3-
oxopentanoate 
- 
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 14 11.379 0.2271 340.1314 C20H20O5 Morachalcone A 
Tyrosinase 
Inhibitors 
(Nguyen et al., 
2012), 
inhibition of 
nitric oxide 
(Joo et al., 
2014), 
pancreatic 
lipase 
inhibitory 
(Jeong et 
al.,2015)
15 11.562 3.0017 310.1200 C14H19N4O2Cl Lintopride 
Treatment of 
gastrointestinal 
reflux, nausea 
and vomiting 
(Delvaux et al., 
1995)
16 11.996 0.1281 332.1961 C16H24N6O2 
8-(4-Ethyl-1-
piperazinyl)-3-methyl-
7-(2-methyl-2-propen-
1-yl)-3,7-dihydro-1H-
purine-2,6-dione 
- 
17 12.431 4.2855 503.3096 C25H45NO9 Pederin 
Antioxidant, 
anticancer 
(Ghoneim, 
2013)
18 12.614 0.6065 693.3941 C33H59NO14 
Methyl {[(9Z)-17-
{[(2R,3R,4S,5S,6R)-
4,5-dihydroxy-6-
(hydroxymethyl)-3-
{[(2S,3R,4S,5S,6R)-
3,4,5-trihydroxy-6-
(hydroxymethyl)tetrah
ydro-2H-pyran-2-
yl]oxy}tetrahydro-2H-
pyran-2-yl]oxy}-9-
octadecenoyl]ami 
no}acetate 
- 
19 12.911 0.2985 363.3127 C18H42N5Cl Unknown  
20 13.208 0.7061 276.2087 C18H28O2 Phenyl laurate 
Antimicroba, 
antihipertensio
n (Edwin and 
Edmund,1940)
21 13.460 0.3641 495.3566 C24H46N9Cl Unknown  
22 13.791 2.6389 531.3408 C2H37N29O2S Unknown  
23 14.306 0.8403 698.5889 C30H75N14O2Cl Unknown  
24 15.541 21.6948 698.5885 C8NO15S6Br2 Unknown  
25 16.718 11.5201 698.5896 C43H86S3 Unknown  
26 17.153 11.2271 592.2689 C35H36N4O5 Pheophorbide A 
Antiinflamatio
n, antioxidant 
(Vencl et al., 
2009), anti-
HIV (Zhang et 
al., 2003)
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 27 17.370 0.6928 592.2694 C36H40N4S2 
1,1'-(1,4-
Butanediyl)bis{2,6-
dimethyl-4-[(3-
methyl-1,3-
benzothiazol-2(3H)-
ylidene)methyl]pyridin
ium}
- 
28 18.330 33.0776 698.5885 C8NO15S6Br2 Unknown - 
 
Table 1 and Table 2 summarise all the 
compounds characterized in ethyl acetate extract of 
M. crenata, including retention times, % area, 
measured m/z, molecular formula, putative 
compounds, and its activity based on references. 
In total there were 32 peak of compounds 
identified in the DCM solvent, and 28 peak in the 
methanol solvent. The use of two types of solvent 
aimed to elute the ethyl acetate extract optimally. 
From all the peaks, only 36 peaks can be identified, 
while the rest are unknown compounds. 
Unknown compounds may be identified as 
impure compounds which are still detected by the 
instrument, or they may be a new compounds, which 
is undetectable in chemspider database, especially 
unknown compounds with high concentrations. 
Based on the results of this study, it is not yet 
known which compounds are likely to have activity 
as phytoestrogens, but when viewed from the 
activity data in Table 1 and Table 2, it is known 
some compounds have activity as antioxidants. 
Where antioxidants is one form of phytoestrogens 
activity, the ER-independent pathway. 
Phytoestrogens can work through two pathways, 
both ER-dependent and ER-independent pathway. 
Although most biological actions of phytoestrogens 
are mediated through ERs in cells (ER-dependent), 
its can exert antioxidant effects and suppress 
oxidative stress through an ER-independent 
pathway. Phytoestrogens effectively prevent pro-
oxidant stress by limiting ROS release from 
damaged mitochondria, and provides antioxidant 
activity in cells (Cui et al., 2013). 
4 CONCLUSIONS 
From UPLC-QToF-MS/MS analysis, it is concluded 
that ethyl acetate extract of M. crenata leaves 
contain various types of compounds, either detected 
compounds (36 compounds), or unknown 
compounds. The unknown compounds still need to 
be investigated further, especially those with high 
concentrations.  
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